Changes in Bile Acid Composition and Effect on Cytolytic Activity of Fecal Water by Ursodeoxycholic Acid Administration: a Placebo-Controlled Cross-over Intervention Trial in Healthy Volunteers

Background: Ursodeoxycholic acid (UDCA) has been shown to affect membrane-damaging effects of bile acids in vitro and fecal bile acid composition in rats. This study evaluates the effect of UDCA on fecal bile acid composition and on cytolytic activity of fecal water in man to clarify the potential chemopreventive role of UDCA for colorectal cancer. Methods: In this placebo-controlled crossover intervention trial, the effect of 900 mg/day UDCA orally in 15 healthy volunteers was studied. At the end of each 4-week period, 72 h feces were collected. Total and individual bile acids in feces were determined by gas chromatography and soluble bile acids were analyzed by high-performance liquid chromatography. Cytolytic activity of fecal water was measured using an erythrocyte lysis assay. Results: In feces, the percentages of primary bile acids--cholic acid (CA) and chenodeoxycholic acid (CDCA)--and of secondary bile acid--deoxycholic acid (DCA)--decreased after supplementation with UDCA, whereas those of UDCA and LCA increased from 2.7 ± 0.4% to 23.7 ± 2.6%, P < 0.0001 and from 26.2 ± 1.2% to 49.4 ± 1.8%, P < 0.0001 respectively. The concentrations of these two bile acids in fecal water also increased after UDCA administration from 7.8 ± 1.9 μmol/l to 47.0 ± 6.7 μmol/l (UDCA), P < 0.0001 and from 2.5 ± 0.6 μmol/l to 18.3 ± 4.1 μmol/l (LCA), P < 0.002, respectively. Cytolytic activity of fecal water was not affected by UDCA. Conclusion: These results do not support a protective effect of UDCA supplementation against colorectal cancer in man.

[1]  J. H. Meerwaldt,et al.  New method for the determination of bile acid turnover using 75Se-homocholic acid taurine , 1982, European Journal of Nuclear Medicine.

[2]  A. Larghi,et al.  Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine‐conjugated species in patients with primary biliary cirrhosis , 1999, Hepatology.

[3]  D. Alberts,et al.  Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. , 1998, Cancer research.

[4]  L. Roncucci,et al.  Chemoprevention of colorectal tumors: role of lactulose and of other agents. , 1997, Scandinavian journal of gastroenterology. Supplement.

[5]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[6]  R. van der Meer,et al.  Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. , 1996, Cancer research.

[7]  C. Steer,et al.  The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. , 1995, Gastroenterology.

[8]  C. Steer,et al.  Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate. , 1995, Gastroenterology.

[9]  A. Bhattacharyya,et al.  Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. , 1994, Cancer research.

[10]  N. W. Ross,et al.  Toxicity of bile acids to colon cancer cell lines. , 1993, Cancer letters.

[11]  R. van der Meer,et al.  Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water. , 1993, Cancer research.

[12]  G. Paumgartner,et al.  Increased serum deoxycholic acid levels in men with colorectal adenomas. , 1993, Gastroenterology.

[13]  T. Sauerbruch,et al.  Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial , 1992, Hepatology.

[14]  R. van der Meer,et al.  Lytic effects of mixed micelles of fatty acids and bile acids. , 1992, The American journal of physiology.

[15]  A. Cats,et al.  Changes in rectal epithelial cell proliferation and intestinal bile acids after subtotal colectomy in familial adenomatous polyposis. , 1992, Cancer research.

[16]  R. van der Meer,et al.  Diet-induced increase of colonic bile acids stimulates lytic activity of fecal water and proliferation of colonic cells. , 1992, Carcinogenesis.

[17]  R. van der Meer,et al.  Dietary calcium phosphate inhibits cytotoxicity of fecal water. , 1991, The American journal of physiology.

[18]  A. Velardi,et al.  Cell type-dependent effect of phospholipid and cholesterol on bile salt cytotoxicity. , 1991, Gastroenterology.

[19]  R. V. D. Meer,et al.  Sensitive pulsed amperometric detection of free and conjugated bile acids in combination with gradient reversed-phase HPLC , 1991 .

[20]  P. Hylemon,et al.  Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. , 1991, Gastroenterology.

[21]  M. Pike,et al.  Increased cell division as a cause of human cancer. , 1990, Cancer research.

[22]  P. Galle,et al.  Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes , 1990, Hepatology.

[23]  R. Raedsch,et al.  Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. , 1990, Gastroenterology.

[24]  J. Scholes,et al.  Effects of calcium and bile acid feeding on colon tumors in the rat. , 1989, Cancer research.

[25]  R. Raedsch,et al.  Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment. , 1988, Gastroenterology.

[26]  G. Salvioli,et al.  Urinary excretion of bile acids during acute administration in man , 1988, European journal of clinical investigation.

[27]  H. Popper,et al.  URSODEOXYCHOLIC ACID FOR PRIMARY BILIARY CIRRHOSIS , 1987, The Lancet.

[28]  W. R. Bruce,et al.  Cellular toxicity of fecal water depends on diet. , 1987, The American journal of clinical nutrition.

[29]  K. Einarsson,et al.  Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics * , 1986, European journal of clinical investigation.

[30]  R. Owen,et al.  Steroids and cancer: faecal bile acid screening for early detection of cancer risk. , 1986, Journal of steroid biochemistry.

[31]  K. Setchell,et al.  Fecal bile acid profiles of Japanese patients with adenomatous polyps of the large bowel: special reference to distribution, multiplicity, size and degree of dysplasia of the polyps. , 1985, Japanese journal of cancer research : Gann.

[32]  J. Schölmerich,et al.  Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles , 1984, Hepatology.

[33]  W. R. Bruce,et al.  Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. , 1983, Carcinogenesis.

[34]  K. Setchell,et al.  Serum bile acid analysis. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[35]  M. Merrick,et al.  Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment. , 1983, Gastroenterology.

[36]  L. Marnett,et al.  Stimulation of deoxythymidine incorporation in the colon of rats treated intrarectally with bile acids and fats. , 1983, Carcinogenesis.

[37]  B. White,et al.  7 beta-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708. , 1982, Journal of lipid research.

[38]  A. Hofmann,et al.  Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. , 1979, The Journal of laboratory and clinical medicine.

[39]  I. Makino,et al.  Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid. , 1978, Journal of lipid research.

[40]  V. Aries,et al.  Faecal steroid composition and its relationship to cancer of the large bowel , 1971, The Journal of pathology.